14 Biotech Stocks with High Potential

Page 4 of 13

10. BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)

Analyst Upside: 74.09%

Number of Hedge Fund Holders: 58

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the best biotech stocks with high potential. BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) reported total revenues of $825 million in fiscal Q2 2025, up 16% year-over-year and up 17% year-over-year at constant currency. GAAP diluted earnings per share (EPS) for the quarter reached $1.23.

In a report released on September 17, Christopher Raymond from Raymond James maintained a Buy rating on BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) and set a price target of $85.00.

In addition to Raymond James, Wedbush’s Yun Zhong also expressed bullish sentiments for BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) in a report released on September 8, assigning the stock a Buy rating. However, the same day, H.C. Wainwright initiated coverage of the stock with a Hold rating and a $60 price target.

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) develops and commercializes therapies for serious and life-threatening medical conditions and rare diseases. The company’s product pipeline includes Valoctocogene roxaparvovec, Vosoritide, and BMN 307.

Page 4 of 13